Skip to content
pharmaceutical hero image
pharmaceutical hero image

Pharmaceuticals

We act for many of the world’s largest pharmaceutical companies, giving us broad and deep insights into the key trends and risks facing companies operating in the sector.

We advise on a wide range of complex cases, working with both national and international clients on high-profile and strategic matters. We have gathered significant and relevant experience of acting for leading companies in the life sciences sector on regulatory issues and we have built a track record of running a number of multi-jurisdictional matters. We also have a strong offering advising pharmaceuticals on transactions including M&A, collaborations and fundraising. Our clients include Novartis, Pfizer, Bayer, Merck, GSK, and Johnson & Johnson among many others.

News & insights

Multiple test tubes and dropper

Blog Post: 25 January 2022

Belgian medicines agency updates procedure to remove patented indications from SmPC and package leaflet

The Belgian Federal Agency for Medicines and Health Products (the FAMHP) has reviewed its procedure to remove or add patented therapeutic indications or dosage forms from the generic medicines'…

Read more
Science lab setting with plant, computer, flask and microscope

Blog Post: 21 January 2022

Kickoff of the UPC: UPC Protocol on Provisional Application now in force

On 19 January 2022, the Unified Patent Court (UPC) came to life as an international organisation. Now, the preparatory phase for the official start of the UPC system can begin.

Read more
Microscopic image of cell

Blog Post: 05 January 2022

COVID-19 – the distinction between vaccines and vaccination

Vaccines With thanks to a huge global scientific effort, we now have several COVID-19 vaccines that have met the standards of safety and efficacy set by regulators. 

Read more
Green liquid being dropped into test tube

Blog Post: 23 November 2021

The Belgian Joint Commission’s Chamber for Products for Human Use no longer considers oral nicotine pouches to qualify as medicinal products

In a new decision dated 24 September 2021, the Belgian Joint Commission's Chamber for Products for Human Use reversed its previous decision dated 27 November 2020, and now considers that oral nicotine…

Read more

Download our sector brochure

Life sciences A&O red molecules

An insight in to our Life Science and Healthcare sector 2022

Our global Life Sciences and Healthcare sector comprises a multi-disciplinary team. We act for companies and their investors across the industry, including in the pharmaceuticals, biotech, animal health, consumer health, med tech, and diagnostics sectors.